Infectious Diseases and Clinical Microbiology

Uzm. Dr. Sedef Başgönül

Doctor and researcher Medipol Mega Üniversite Hastanesi İstanbul
İngilizce
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

CV

Education and experience

From source

Experience

  • 2020 - 2026Acıbadem Maslak HastanesiUzm.Dr.
  • 2020 - 2020Özel Medipol Mega Hastaneler KompleksiUzm.Dr.
  • 2018 - 2020Biga Devlet HastanesiUzm.Dr.
  • 2016 - 2018Kars Devlet HastanesiUzm.Dr.
  • 2009 - 2011Gökçeada Devlet HastanesiPra.Dr.

Education

  • 2016İstanbul Kartal Dr.Lütfi Kırdar Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyolojimedipol.com.tr
  • 2009Yeditepe Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologymedipol.com.trFrom source
  • InstitutionMedipol Mega Üniversite Hastanesimedipol.com.trFrom source
  • Publications8 publicationsOpenAlex, ORCIDFrom source
  • Languagesİngilizcemedipol.com.trFrom source
  • ORCID0000-0003-2764-9742ORCIDFrom source
  • Last synchronised4 November 2026 20:23https://medipol.com.tr/doktorlarimiz/uzmdr-sedef-basgonulmedipol.com.tr

Scientific work

Publications

8 publications
Publications by year Most: 4, in 2024
  1. 2013: 1 publication
  2. 2014: 0 publications
  3. 2015: 1 publication
  4. 2016: 0 publications
  5. 2017: 0 publications
  6. 2018: 1 publication
  7. 2019: 0 publications
  8. 2020: 1 publication
  9. 2021: 0 publications
  10. 2022: 0 publications
  11. 2023: 0 publications
  12. 2024: 4 publications

  1. Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-77259-z PMID 39487308 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

    Antibiotics, 2024

    DOI 10.3390/antibiotics13100990 PMID 39452256 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Ceftazidime-Avibactam versus Polymyxin-Based Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48 Endemic Region

    Journal of Global Antimicrobial Resistance, 2024

    DOI 10.1016/j.jgar.2024.10.005 Open-access full textSource: OpenAlex

  4. Registry-Based Retrospective Cohort Study of Mortality among Adults Admitted to Intensive Care Units in Istanbul with Hospital Acquired Pseudomonas aeruginosa Bloodstream-Infection between 2014–2021

    Antibiotics, 2024

    DOI 10.3390/antibiotics13010090 PMID 38247649 6 citations (Europe PMC) Open-access full textSource: ORCID

  5. Efficacy of Lopinavir Combined with Doxycycline for Treatment of COVID-19: A Retrospective Comparison of Two Cohorts

    2020

    DOI 10.22541/au.159493283.36857508 Open-access full textSource: OpenAlex

  6. Evaluation of the Side Effects of Antiretroviral Treatment

    Mediterranean Journal of Infection Microbes and Antimicrobials, 2018

    DOI 10.4274/mjima.2018.11 Open-access full textSource: ORCID

  7. Antibiotic Resistance Patterns of Escherichia coli and Klebsiella pneumoniae Strains Isolated from Clinical Specimens

    Türk Mikrobiyoloji Cemiyeti Dergisi, 2015

    DOI 10.5222/tmcd.2014.101 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. Odontogenic Descending Necrotizing Mediastinitis in a Patient with Severe Allergy to Beta-Lactam Antibiotics: A Case Report and Literature Review

    DOAJ (DOAJ: Directory of Open Access Journals), 2013

    Open-access full textSource: OpenAlex